Retraction: The immunoregulation effect of alpha 1-antitrypsin prolong β-cell survival after transplantation(PLoS ONE (2014) 9:4 (e94548) DOI: 10.1371/journal.pone.0094548);The immunoregulation effect of alpha 1-antitrypsin prolong β-cell survival after transplantation

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Wang, Yun ^a,b   Yan, Hong Jie ^b   Zhou, Shu Yan ^b   Wang, Yun Shuang ^b   Qi, Hui ^b   Deng, Chun Yan ^b   Li, Fu Rong ^b,c  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c Shenzhen Institute of Geriatrics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; C PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; IMMUNOLOGIC FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; GENETICS; GRAFT REJECTION; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PANCREAS ISLET BETA CELL; PATHOLOGY; TH1 TH2 BALANCE; TRANSGENE; TRANSPLANTATION;

ALPHA 1-ANTITRYPSIN; ANIMALS; APOPTOSIS; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; INSULIN-SECRETING CELLS; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; TH1-TH2 BALANCE; TRANSGENES;

EID: 84899526359     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0200182     Document Type: Erratum

References (30)

1. Mathis D, Vence L, Benoist C (2001) Beta-cell death during progression to diabetes. Nature 414:792-8.
2. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, et al. (2006) Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J v. 355:1318-1330.
3. Robertson RP (2010) Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes.59:1285-91.
4. Ludvigsson J (2010) Immune intervention in children with type 1 diabetes. Curr Diab Rep.10:370-9.
5. Brantly ML, Wittes JT, Vogelmeier CF, Hubbard RC, Fells GA, et al. (1991) Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest.100:703-8.
6. Churg A, Dai J, Zay K, Karsan A, Hendricks R, et al. (2001) Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest. 81:1119-31. (Pubitemid 32772072)
7. Jie Z, Cai Y, Yang W, Jin M, Zhu W, et al. (2003) Protective effects of alpha 1-antitrypsin on acute lung injury in rabbits induced by endotoxin. Chin Med J (Engl). 116:1678-82. (Pubitemid 38008236)
8. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA (2005) Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA 102:12153-12158. (Pubitemid 41291144)
9. Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, et al. (2006) A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema.Am J Respir Crit Care Med.173:1222-8. (Pubitemid 43848392)
10. Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, et al. (2007) Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes. 56:1316-23.
11. Brantly M (2002) Alpha1-antitrypsin: Not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am J Respir Cell Mol Biol 27:652-654.
12. Lu Y1, Tang M, Wasserfall C, Kou Z, Campbell-Thompson M, et al. (2006) Alpha1- antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum Gene Ther. 17:625-34.
13. Lewis EC1, Mizrahi M, Toledano M, Defelice N, Wright JL, et al. (2008) alpha1- Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A. 105:16236-41.
14. Hamaguchi K, Gaskins H, Leiter E (1991) NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40:842-849.
15. Wei P, Li L, Qi H, Zhou HX, Deng CY, et al. (2012) Reversible immortalization of Nestin-positive precursor cells from pancreas and differentiation into insulin-secreting cells. Biochem Biophys Res Commun.418:330-5.
16. Weir GC, Koulamnda M (2009) Control of inflammation with alpha1-antitrypsin: a potential treatment for islet transplantation and new-onset type 1 diabetes. Curr Diab Rep. 9:100-2.
17. Ye J, Liao YT, Jian YQ, Zhang XD, Wei P, et al. (2013) Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation. Immunology Letters.150:61-8.
18. Bertuzzi F, Marzorati S, Maffi P, Piemonti L, Melzi R, et al. (2004) Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab. 89:5724-8. (Pubitemid 39518465)
19. Abdi R, Means TK, Ito T, Smith RN, Najafian N, et al. (2004) Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. J Immunol. 172:767-75. (Pubitemid 38113732)
20. Böni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, et al. (2008) Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta - cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93:4065-74.
21. Ottaviani S, Gorrini M, Scabini R, Kadija Z, Paracchini E, et al. (2011) C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants.Transl Res. 157:332-8.
22. Slobedman B, Barry PA, Spencer JV, Avdic S, Abendroth A (2009) Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.J Virol. 83:9618-29.
23. Ozeri E, Mizrahi M, Shahaf G, Lewis EC (2012) á-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells. J Immunol. 189:146-53.
24. Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, et al. (2012) Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 109:564-9.
25. Koulmanda M, Bhasin M, Fan Z, Hanidziar D, Goel N, et al. (2012) Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival. Proc Natl Acad Sci U S A 109:15443-8.
26. Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, et al. (2007) Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes. 56: 1316-23.
27. Kalis M, Kumar R, Janciauskiene S, Salehi A, Cilio CM (2010)a 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic β-cells. Islets. 2:185-9.
28. Shahaf G, Moser H, Ozeri E, Mizrahi M, Abecassis A, et al. (2011) α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol Med. 17:1000-11.
29. Walters S, Webster KE, Sutherland A, Gardam S, Groom J, et al. (2009) Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol. 182:793-801.
30. Pott GB, Chan ED, Dinarello CA, Shapiro L (2009) Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol. 85:886-95.